Open sidebar
Focus
antibody drug
LATEST
US News
|
Bill Pan
FDA Pulls Authorization for Evusheld, Says It’s Ineffective Against New COVID Mutations
Jan 27, 2023
|
Bill Pan
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Jan 27
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
AMERICA
|
Katabella Roberts
AstraZeneca’s COVID-19 Prevention Drug Granted Emergency Authorization for Immune Compromised
Dec 09, 2021
|
Katabella Roberts
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Dec 09
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
PUBLIC HEALTH INFORMATION
|
Isabel van Brugen
FDA Grants Eli Lilly’s Experimental COVID-19 Antibody-Drug Emergency Use Authorization
Feb 10, 2021
|
Isabel van Brugen
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Feb 10
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US News
|
Bill Pan
US to Pay Eli Lilly $375 Million for 300,000 Vials of Experimental COVID-19 Antibody Drug
Oct 28, 2020
|
Bill Pan
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oct 28
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
